Company Filing History:
Years Active: 2025
Title: Kurtis E Bachman: Innovator in JAK Inhibition
Introduction
Kurtis E Bachman is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of small molecule inhibitors targeting the JAK family of kinases. His work is crucial in addressing various disease states and disorders.
Latest Patents
Kurtis E Bachman holds 1 patent for a small molecule inhibitor of the JAK family of kinases. This patent discloses JAK inhibitors that exhibit low systemic toxicity. The invention includes methods for treating disease states mediated by JAK, such as cancers of the stomach and intestinal system, including colorectal cancers and familial adenomatous polyposis.
Career Highlights
Kurtis is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions for complex medical challenges.
Collaborations
Kurtis has collaborated with esteemed colleagues, including Edward F Attiyeh and Gerald C Chu. These partnerships have enhanced the research and development of effective treatments in their field.
Conclusion
Kurtis E Bachman is a prominent figure in the realm of JAK inhibition, with a focus on developing therapies for serious health conditions. His contributions continue to impact the pharmaceutical landscape positively.